Tsewang Tashi
( out of 61 reviews )

Tsewang Tashi, MD

Languages spoken: Tibetan, English, Mandarin Chinese, French, Hindi, Urdu

Clinical Locations

Huntsman Cancer Institute - Cancer Research North

Clinic 2D/E, BMT/Hematology
Salt Lake City
801-585-0236

South Jordan Health Center

South Jordan
801-213-4500

VA - Building #14

Hematology/Oncology
Salt Lake City
801-582-1565

  • Dr. Tsewang Tashi joined the University of Utah faculty after completing his hematology/oncology fellowship in 2015. He received his medical degree from Chang Gung University, Taiwan, and completed his internal medicine residency both in Taiwan, and in the US from Creighton University Medical Center, Omaha, NE. Early in his career during fellowship, he has been involved in research with Dr. Josef Prchal on high altitude genetic adaptation, hypoxia signaling and molecular genetics of myeloproliferative neoplasms.

    His research and clinical interest lies in myeloid malignancies and currently sees and manages patients with myeloproliferative neoplasms, including systemic mastocytosis, and acute leukemias, both at the Huntsman Cancer Institute and serving the veterans at the George E. Whalen VA Medical Center in Salt Lake City. He established and currently leads the Mastocytosis Program at the Huntsman Cancer Hospital, which has been designated as Mastocytosis Center of Excellence. He also runs several clinical trials as the principal investigator in polycythemia vera, essential thrombocythemia, systemic mastocytosis and acute leukemia.

    At the VA Medical Center, he is one of the lead hematologists and cares for all the veterans with acute leukemias, myelodysplastic syndromes and myeloproliferative neoplasms that are referred to Salt Lake City VA from different parts of the Intermountain West. He also leads several research projects and conducts clinical trials.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Patient Rating

    5.0 /5
    ( out of 61 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    December 28, 2023
    HUNTSMAN CANCER CENTER

    Dr. Tashi was very knowledgeable and helped me to understand my diagnosis better.

    December 28, 2023
    HUNTSMAN CANCER CENTER

    What a truly outstanding doctor Dr. Tashi is. He spent 70 minutes with us and answered all our concerns and questions. Helped with the pros and cons of my health issue.

    December 07, 2023
    HUNTSMAN CANCER CENTER

    In my near 70 years of experience I¿ve met few physicians of his caliber. You are lucky to have him and your patients, including me, are even luckier.

    November 30, 2023
    HUNTSMAN CANCER CENTER

    Dr. Tashi was well informed about my conditions, did an excellent job listening, answering questions, and he has a pleasant demeanor.

    November 16, 2023
    HUNTSMAN CANCER CENTER

    Very caring and knowledgeable about PV

    November 09, 2023
    SOUTH JORDAN HEALTH CENTER

    Repeat my first comments. Dr Tashi is awesome!

    October 06, 2023
    HUNTSMAN CANCER CENTER

    He explained everything in a way that was easy to understand. I didn't feel rushed and felt comfortable asking my questions.

    October 05, 2023
    HUNTSMAN CANCER CENTER

    Dr. Tashi is a kind and caring man. He doesn't rush, he listen and explains things in away that I can understand. I have many problems and DR. Tashi is willing to work with my other doctors to help figure out how to best help me. Deborah

    August 04, 2023
    HUNTSMAN CANCER CENTER

    Superb

    See More Patient Comments

  • Dr. Tsewang Tashi joined the University of Utah faculty after completing his hematology/oncology fellowship in 2015. He received his medical degree from Chang Gung University, Taiwan, and completed his internal medicine residency both in Taiwan, and in the US from Creighton University Medical Center, Omaha, NE. Early in his career during fellowship, he has been involved in research with Dr. Josef Prchal on high altitude genetic adaptation, hypoxia signaling and molecular genetics of myeloproliferative neoplasms.

    His research and clinical interest lies in myeloid malignancies and currently sees and manages patients with myeloproliferative neoplasms, including systemic mastocytosis, and acute leukemias, both at the Huntsman Cancer Institute and serving the veterans at the George E. Whalen VA Medical Center in Salt Lake City. He established and currently leads the Mastocytosis Program at the Huntsman Cancer Hospital, which has been designated as Mastocytosis Center of Excellence. He also runs several clinical trials as the principal investigator in polycythemia vera, essential thrombocythemia, systemic mastocytosis and acute leukemia.

    At the VA Medical Center, he is one of the lead hematologists and cares for all the veterans with acute leukemias, myelodysplastic syndromes and myeloproliferative neoplasms that are referred to Salt Lake City VA from different parts of the Intermountain West. He also leads several research projects and conducts clinical trials.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Hematology
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Education history

    Graduate Training Master of Science in Clinical Investigation - University of Utah M.S.C.I
    Hematology/Oncology - University of Utah Fellow
    Residency Internal Medicine - Creighton University Resident
    Internal Medicine - Pingtung Christian Hospital Resident
    Internship Internal Medicine - MacKay Memorial Hospital Intern
    Medicine - Chang Gung University School of Medicine M.D.

    Selected Publications

    Journal Article

    1. Gotlib J, Castells M, Elberink HO, Siebenhaar F, Hartmann K, Broesby-Olsen S, George TI, Panse J, Alvarez-Twose I, Radia DH, Tashi T, Bulai Livideanu C, Sabato V, Heaney M, Van Daele P, Cerquozzi S, Dybedal I, Reiter A, Pongdee T, Barete S, Ustun C, Schwartz L, Ward BR, Schafhausen P, Vadas P, Bose P, DeAngelo DJ, Rein L, Vachhani P, Triggiani M, Bonadonna P, Rafferty M, Butt NM, Oh ST, Wortmann F, Ungerstedt J, Guilarte M, Taparia M, Kuykendall AT, Arana Yi C, Ogbogu P, Gaudy-Marqueste C, Mattsson M, Shomali W, Giannetti MP, Bidollari I, Lin HM, Sulllivan E, Mar B, Scherber R, Roche M, Akin C, Maurer M (2023). Avapritinib versus Placebo in Indolent Systemic Mastocytosis. NEJM Evid, 2(6), EVIDoa2200339. (Read full article)
    2. Tashi T, Yu J, Pandya S, Dieyi C, Scherber R, Parasuraman S (2023). Trends in overall mortality among US veterans with primary myelofibrosis. BMC Cancer, 23(1), 48. (Read full article)
    3. Chuah YY, Tashi T, Kuo CJ (2022). An unexpected cause of Cullen's sign: rupture of hepatocellular carcinoma. Br J Hosp Med (Lond), 83(11), 1. (Read full article)
    4. Verstovsek S, Mesa R, Mascarenhas J, Tashi T, Shih W, Sato T, Urbanski R, Zagrijtschuk O, Zimmerman C (2022). MPN-546 A Single-Arm Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Ropeginterferon alfa-2b-njft (P1101) in North American Adults With Essential Thrombocythemia. Clin Lymphoma Myeloma Leuk, 22 Suppl 2, S342-S343. (Read full article)
    5. Feusier JE, Arunachalam S, Tashi T, Baker MJ, VanSant-Webb C, Ferdig A, Welm BE, Rodriguez-Flores JL, Ours C, Jorde LB, Prchal JT, Mason CC (2021). Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers. Blood Cancer Discov, 2(3), 226-237. (Read full article)
    6. Gangaraju R, Song J, Kim SJ, Tashi T, Reeves BN, Sundar KM, Thiagarajan P, Prchal JT (2019). Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia. Blood Adv, 4(6), 1115-1130. (Read full article)

    Review

    1. Tashi T, Deininger MW (2023). Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms. [Review]. Immunol Allergy Clin North Am, 43(4), 723-741. (Read full article)
    2. Tashi T (2022). Hematocrit, White Blood Cells, and Thrombotic Events in the Veteran Population With Polycythemia Vera. [Review]. Fed Pract, 39(Suppl 2), S43-S46. (Read full article)

    Case Report

    1. Chuah YY, Tashi T, Lee YY, Fu TY, Shih CA (2020). Enteropathy-associated T-cell Lymphoma (EATL) with intracranial metastasis : a rare and dismal condition. Acta Gastroenterol Belg, 83(1), 77-80. (Read full article)

    Editorial

    1. Song J, Tashi T, Prchal JT (2019). Editorial Comment on: Inhibition of Suicidal Erythrocyte Death by Chronic Hypoxia by Tang et al. (From: Tang F, Feng L, Li R, Wang W, Liu H, Yang Q, Ge R-L. High Alt Med Biol 2019;20:112-119; DOI: 10.1089/ham.2017.0159). High Alt Med Biol, 20(2), 120-121. (Read full article)

  • News & Podcasts

    Huntsman Cancer Institute News